Open | $2.070 |
Close | $2.180 |
Volume / Avg. | 45.789K / 83.787K |
Day Range | 2.070 - 2.210 |
52 Wk Range | 1.490 - 20.660 |
Market Cap | $9.500M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 1.83% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.
Other companies in Hepion Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Brookline Capital on Thursday, December 7, 2023. The analyst firm set a price target for 0.00 expecting HEPA to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $2.19 last updated March 18, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Hepion Pharmaceuticals.
Hepion Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.